Runway Growth Finance Corp. (RWAY) Earnings

Runway Growth Finance Corp. is expected to report next earnings on August 6, 2026 (in NaN days), with a consensus EPS estimate of $0.29. RWAY has beaten EPS estimates in 6 of its last 12 reported quarters (average surprise -0.8% over the last four).

Next earnings
Aug 6, 2026in NaN days
EPS est $0.29 · Revenue est $32M
Track record
Beat EPS in 6 of 12 quarters
Avg surprise -0.8% (last 4 quarters)
Earnings history
Report dateEPS estEPS actualSurpriseRevenueRev. surprise
May 7, 2026$0.31$0.29-6.5%$29M-0.1%
Mar 12, 2026$0.35$0.32-7.5%$30M-6.2%
Nov 6, 2025$0.38$0.43+13.2%$21M-33.6%
Aug 7, 2025$0.39$0.38-2.6%$34M-4.2%
Mar 20, 2025$0.42$0.39-7.1%$60M+77.0%
Aug 8, 2024$0.43$0.37-14.0%$34M-11.6%
Mar 7, 2024$0.49$0.45-8.2%$22M-45.5%
Mar 2, 2023$0.39$0.45+15.4%$21M-47.2%
Nov 3, 2022$0.35$0.36+2.9%$14M-45.2%
Aug 4, 2022$0.32$0.35+9.4%$910000-95.8%
May 5, 2022$0.29$0.30+3.4%$5M-75.3%
Mar 3, 2022$0.26$0.28+7.7%$21M+12.5%

Source: company filings + earnings calendar. For informational purposes only — not investment advice.

Earnings call summary

Q1 FY2026 · May 7, 2026

AI summary of management’s prepared remarks and analyst Q&A. For informational purposes only — not investment advice.

Management highlights

David Spreng highlighted the closing of the SWK transaction, welcomed new leadership appointments like JD Thomas and Avisha Kubani's promotion, and Thomas B. Raterman's new role. First quarter portfolio activity included 4 investments totaling $17.6 million. Discussed market dynamics, private credit resilience, and software investment approach.

Guidance

Expects SWK integration to be accretive to EPS starting in Q2, fully accretive in Q3. Announces a new share repurchase program for $15 million expiring on 05/07/2027.

Segment performance

First quarter 2026: Total investment income was $29.5 million, net investment income was $10.6 million. Total investment portfolio fair value was $886.3 million, a decrease of 4.4% from $927.4 million in 2025. Net assets of Runway Growth Finance Corp. were $438.2 million, NAV per share was $12.13, a decrease of 9.6% compared to $13.42 as of 12/31/2025. Health care and life sciences sector comprised 32% of the portfolio at fair value.

Risks & headwinds

Risks include market conditions caused by uncertainties surrounding interest rates, changing economic conditions, and recent credit downgrades of Marley Spoon and BlueShift to nonaccrual status.

Analyst Q&A

  • Q: Erik Zwick asked about one-time expenses related to SWK acquisition and accelerated debt expense, and how to weigh capital use between investing and buying back shares.

    A: Thomas B. Raterman responded about early redemption of baby bonds and balancing capital use.

  • Q: Christopher Nolan asked about driver of unrealized depreciation charges and time frame for SWK to be accretive to EPS.

    A: Thomas B. Raterman answered about causes of depreciation and SWK's accretive timeline.